Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SHWZ | Series A Cumulative Convertible Preferred Stock | Award | $547K | +547 | +22.39% | $1,000.00* | 2.99K | Mar 2, 2021 | Common stock | 456K | $1.20 | Direct | F1, F2, F3 |
transaction | SHWZ | Series A Cumulative Convertible Preferred Stock | Award | $865K | +865 | +28.93% | $1,000.00* | 3.86K | Mar 2, 2021 | Common stock | 721K | $1.20 | Spouse | F1, F2, F3 |
transaction | SHWZ | Series A Cumulative Convertible Preferred Stock | Award | $547K | +547 | +7.67% | $1,000.00* | 7.68K | Mar 2, 2021 | Common stock | 3.19M | $1.20 | Spouse | F1, F2, F3 |
transaction | SHWZ | Warrant (Right to Buy) | Award | +103K | 103K | Mar 2, 2021 | Common stock | 103K | $1.20 | Direct | F4 | |||
transaction | SHWZ | Warrant (Right to Buy) | Award | +162K | +158.02% | 265K | Mar 2, 2021 | Common stock | 162K | $1.20 | Spouse | F4 | ||
transaction | SHWZ | Warrant (Right to Buy) | Award | +718K | +271.31% | 982K | Mar 2, 2021 | Common stock | 718K | $1.20 | Spouse | F4 |
Id | Content |
---|---|
F1 | Subject to adjustment, as described in the Certificate of Designation. |
F2 | The shares of Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Shares") are convertible into shares of the common stock (the "Common Shares") of Medicine Man Technologies, Inc. (the "Company") upon the events specified in the Company's Certificate of Designation of Series A Cumulative Convertible Preferred Stock (the "Certificate of Designation"). The Preferred stock is perpetual and therefore has no expiration date. |
F3 | Represents the number of Common Shares issuable upon conversion of the Series A Preferred Shares on the date of the reported transaction. Each Series A Preferred Share is convertible into that number of Common Shares equal to the preference amount (initially $1,000) plus any accrued dividends with respect to such share, divided by the conversion price (initially $1.20), subject to adjustment as set forth in the Certificate of Designation. The Series A Preferred Shares earn a cumulative dividend of 8% per annum. |
F4 | The reporting person received the warrants under Asset Purchase Agreements entered into by entities partly-owned by the reporting person upon the sale of assets by such entities to the issuer on the following date: March 3, 2021. |